Novum’s Bioanalytical Laboratory in Canada is a one-stop solution for all your bioanalytical needs, supporting the development of pharmaceuticals and biosimilars. Our scientists collaborate with your team to develop robust assays for parent drugs and metabolites, ensuring compliance with sponsor and regulatory requirements. Our commitment to quality is reflected in our processes and systems. Novum’s bioanalytical lab has conducted assays involving small and large molecules, supporting pharmacokinetic and toxicokinetic studies in our state-of-the-art, GLP-compliant facility. Our scientists routinely develop and validate methods, analyzing over 15,000 samples per month. We have developed both complex and proprietary methods for generic and NCE molecules, including sub-picogram detection, endogenous, chiral, and hormonal assays. Our laboratory utilizes advanced automation systems, including EDC and streamlined reporting processes.
We work closely with your team, ensuring quick turnaround times, operational efficiency, and high-quality data.
Our core expertise includes developing and validating robust, reproducible methods and applying them in a high-throughput environment to accelerate the development of prescription medicines (Rx drugs) and generics.
With cutting-edge instrumentation, we are one of the leading bioanalytical service providers in the industry. We deliver high-quality data that meets regulatory requirements and withstands rigorous scrutiny.
Bioanalytical Services:
- Method Development
- Method Validation
- Pharmacokinetic (PK) Analysis
- Bioavailability Studies
- Bioequivalence Studies
- Large Molecule analysis
- Short- and Long-Term Sample Storage with Online Monitoring and Warning System
Comprehensive Lab Capabilities of Lambda-Novum
BIOANALYTICAL METHODS – ASSAY LIST
Explore our comprehensive list of over 1,600 validated bioanalytical assays by Lambda Therapeutic Research & Novum Pharmaceutical Research Services, conducted across a wide range of biological matrices.
- Recently Validated Methods
- Premium Methods
- Large Molecules / Therapeutic Proteins / Biosimilars
- Immunogenicity Assessment
- Small Molecules
- New Chemical Entities
- In-Vitro Studies
- PD Markers
- Healthcare Hygiene Products